TDC A.I CyberSecurity Scoring
02/04/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Tandem Diabetes Care in 2026.
No incidents recorded for Tandem Diabetes Care in 2026.
No incidents recorded for Tandem Diabetes Care in 2026.
Medical Equipment Manufacturing
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.
Latest updates, reports, and threat intel affecting the global network.
March 6 (Reuters) - Medtronic's diabetes business MiniMed fetched a $5.35 billion valuation after its shares opened 4.8% below the offer...
The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate delivery of...
Investing.com - Baird on Tuesday upgraded Tandem Diabetes Care (NASDAQ:TNDM) from Neutral to Outperform and raised its price target to...
Uncover advancements in cyber security and cloud computing at Cyber Security & Cloud Expo North America on 18-19 May 2026 at San Jose McEnery Convention...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of...
Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced it received FDA clearance for the Android version of...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it achieved ISO/IEC 27001:2022 Certification from Insight Assurance.
Certification affirms Tandem's company-wide commitment to cybersecurity, data protection, and operational integrity.
An economic development and “revitalization” task force inside the National Governors Association on Saturday asked its membership to...
In OpenStack Designate before 22.0.2, the mDNS handler performs pool-blind lookups when resolving record queries and NOTIFY requests. When two zones with the same name exist across different pools, the lookup fails with a deterministic error, causing the handler to return REFUSED for all DNS queries through that path. The _handle_notify path is exploitable via a single unauthenticated UDP packet. This is independently reachable through the cross-tenant zone overlap described in a different recent CVE, and also affects legitimate same-tenant cross-pool configurations. BIND9 views do not mitigate this issue as mDNS is a shared service upstream of any view configuration.
In OpenStack Designate before 22.0.1, zone creation checks (_is_subzone, _is_superzone, and the duplicate-zone DB constraint) are scoped to the target pool only. An authenticated user can bypass these checks by scheduling a zone to a different pool via the AttributeFilter scheduler, creating an overlapping zone that conflicts with another tenant's zone. This enables cross-tenant DNS hijack (redirecting traffic to attacker-controlled IPs) and DNS denial of service (NODATA responses). Exploitation requires a multi-pool deployment with AttributeFilter enabled in scheduler_filters, which is a non-default but documented and supported configuration for self-service tiering.
UpSnap is a wake on lan web app. Versions prior to 5.4.0 have an OS command injection vulnerability in the UpSnap’s device management functionality due to the presence of unsafe shell command template interpolation using the ip and the mac fields. User-controlled values can be inserted into the wake_cmd and shutdown_cmd templates and executed via /bin/sh -c (Linux) or cmd /C (Windows) without sanitization, resulting in an authenticated Remote Code Execution (RCE). A low-privileged user with permission to create or edit devices can execute arbitrary operating system commands on the UpSnap hosted server. Version 5.4.0 patches the issue.
FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. When `secureEnabled=true`, FUXA `1.3.0-2773` still allows guest and invalid-token requests to read project, alarms, and scheduler APIs. Version 1.3.1 fixes this issue.
FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. In fuxa-server version 1.3.0, the GET /api/project endpoint exposes sensitive project configuration data to guest-context requests even when secureEnabled is enabled. Version 1.3.1 fixes the issue.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.